Sweet dicer: Impairment of micro-RNA processing by diabetes

Circulation Research

Volumn 117, Issue 2, 2015, Pages 116-118

  Zampetaki, Anna ^a   Mayr, Manuel ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

biological markers; blood platelets; cell nucleus; diabetes mellitus; Editorials; microRNAs

Indexed keywords

ARGONAUTE 2 PROTEIN; DICER; MICRORNA; CALPAIN; DEAD BOX PROTEIN; RIBONUCLEASE III;

DIABETES MELLITUS; DIABETIC PATIENT; EDITORIAL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; RNA PROCESSING; ANIMAL; BLOOD; ENZYMOLOGY; FEMALE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ANIMALS; BLOOD PLATELETS; CALPAIN; DEAD-BOX RNA HELICASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MICRORNAS; PLATELET AGGREGATION; RIBONUCLEASE III;

EID: 84937685416     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.117.306817     Document Type: Editorial

References (15)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136: 215-233. doi: 10.1016/j.cell.2009.01.002
2. Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, Ma L, Chen J, McKnight GS, López JA, Yang L, Jin Y, Bray MS, Leal SM, Dong JF, Bray PF. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood. 2011; 117: 5189-5197. doi: 10.1182/blood-2010-09-299719
3. Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, Renard JM, Mayr A, Weger S, Schett G, Shah A, Boulanger CM, Willeit J, Chowienczyk PJ, Kiechl S, Mayr M. Prospective study on circulating microRNAs and risk of myocardial infarction. J Am Coll Cardiol. 2012; 60: 290-299. doi: 10.1016/j.jacc.2012.03.056
4. Willeit P, Zampetaki A, Dudek K, et al. Circulating microRNAs as novel biomarkers for platelet activation. Circ Res. 2013; 112: 595-600. doi: 10.1161/CIRCRESAHA.111.300539
5. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, Shah A, Willeit J, Mayr M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010; 107: 810-817. doi: 10.1161/CIRCRESAHA.110.226357
6. Mayr M, Zampetaki A, Willeit P, Willeit J, Kiechl S. MicroRNAs within the continuum of postgenomics biomarker discovery. Arterioscler Thromb Vasc Biol. 2013; 33: 206-214. doi: 10.1161/ATVBAHA.112.300141
7. Elgheznawy A, Shi L, Hu J, Wittig I, Laban H, Pircher J, Mann A, Provost P, Randriamboavonjy V, Fleming I. Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes. Circ Res. 2015; 117: 157-165. 10.1161/CIRCRESAHA.117.305784
8. Ge X, Zhao X, Nakagawa A, Gong X, Skeen-Gaar RR, Shi Y, Gong H, Wang X, Xue D. A novel mechanism underlies caspase-dependent conversion of the dicer ribonuclease into a deoxyribonuclease during apoptosis. Cell Res. 2014; 24: 218-232. doi: 10.1038/cr.2013.160
9. Randriamboavonjy V, Isaak J, Elgheznawy A, Pistrosch F, Frömel T, Yin X, Badenhoop K, Heide H, Mayr M, Fleming I. Calpain inhibition stabilizes the platelet proteome and reactivity in diabetes. Blood. 2012; 120: 415-423. doi: 10.1182/blood-2011-12-399980
10. Lugli G, Larson J, Martone ME, Jones Y, Smalheiser NR. Dicer and eIF2c are enriched at postsynaptic densities in adult mouse brain and are modified by neuronal activity in a calpain-dependent manner. J Neurochem. 2005; 94: 896-905. doi: 10.1111/j.1471-4159.2005.03224.x
11. Shi R, Ge L, Zhou X, Ji WJ, Lu RY, Zhang YY, Zeng S, Liu X, Zhao JH, Zhang WC, Jiang TM, Li YM. Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity. Thromb Res. 2013; 131: 508-513. doi: 10.1016/j.thromres.2013.02.015
12. Leierseder S, Petzold T, Zhang L, Loyer X, Massberg S, Engelhardt S. MiR-223 is dispensable for platelet production and function in mice. Thromb Haemost. 2013; 110: 1207-1214. doi: 10.1160/TH13-07-0623
13. Schnall-Levin M, Rissland OS, Johnston WK, Perrimon N, Bartel DP, Berger B. Unusually effective microRNA targeting within repeat-rich coding regions of mammalian mRNAs. Genome Res. 2011; 21: 1395-1403. doi: 10.1101/gr.121210.111
14. Colwell JA, Nesto RW. The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care. 2003; 26: 2181-2188
15. Zampetaki A, Mayr M. MicroRNAs in vascular and metabolic disease. Circ Res. 2012; 110: 508-522. doi: 10.1161/CIRCRESAHA.111.247445